UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050819
Receipt number R000057916
Scientific Title Investigation of the actual condition of sarcopenia in chronic maintenance hemodialysis patients and the effect of renal rehabilitation
Date of disclosure of the study information 2023/04/29
Last modified on 2023/04/11 21:42:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of the actual condition of sarcopenia in chronic maintenance hemodialysis patients and the effect of renal rehabilitation

Acronym

Sarcopenia and Exercise Therapy in Dialysis Patients

Scientific Title

Investigation of the actual condition of sarcopenia in chronic maintenance hemodialysis patients and the effect of renal rehabilitation

Scientific Title:Acronym

Sarcopenia and Exercise Therapy in Dialysis Patients

Region

Japan


Condition

Condition

chronic kidney failure

Classification by specialty

Nephrology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to investigate the prevalence of sarcopenia, frailty, and locomotive syndrome in patients with chronic renal failure and to determine the usefulness of rehabilitation.

Basic objectives2

Others

Basic objectives -Others

Investigating the Association of Adverse Events with Sarcopenia, Frailty, and Locomotive Syndrome in Patients with Chronic Renal Failure.

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Muscle mass, frailty, sarcopenia, locomotive syndrome

Key secondary outcomes

biochemical test data (AST, ALT, LD, ALP, , cholinesterase, CRP, total protein, albumin, BUN, Na, K, Cl, total cholesterol, triglycerides, CK, HbA1c, PT%, PT-INR, red cell count, hemoglobin concentration, white cell count, lymphocyte%, platelet count), physical function assessment (grip strength, limb circumference, balance test, gait speed, exercise stress test, activities of daily living assessment), questionnaires (Life Space Assessment, Locomo 25)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

Age of 20 years or older
Patients who have been prescribed a rehabilitation prescription and have completed it.

Key exclusion criteria

Patients who are deemed inappropriate as research subjects by the principal investigator and assistants.

Target sample size

25


Research contact person

Name of lead principal investigator

1st name Keisuke
Middle name
Last name Hirota

Organization

Kurume University Hospital

Division name

Kurume University Hospital

Zip code

830-0011

Address

67 Asahi-cho, Kurume-shi, Fukuoka

TEL

0942317645

Email

hirota_kerisuke@kurume-u.ac.jp


Public contact

Name of contact person

1st name Keisuke
Middle name
Last name Hirota

Organization

Kurume University Hospital

Division name

Kurume University Hospital

Zip code

830-0011

Address

67 Asahi-cho, Kurume-shi, Fukuoka

TEL

0942317645

Homepage URL


Email

hirota_kerisuke@kurume-u.ac.jp


Sponsor or person

Institute

Kurume University

Institute

Department

Personal name

Hirota Keisuke


Funding Source

Organization

Kurume University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kurume University Hospital

Address

67 Asahimachi, Kurume City, Fukuoka

Tel

0942317645

Email

hirota_keisuke@kurume-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 09 Month 30 Day

Date of IRB

2022 Year 09 Month 30 Day

Anticipated trial start date

2022 Year 09 Month 30 Day

Last follow-up date

2027 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Nothing in particular


Management information

Registered date

2023 Year 04 Month 11 Day

Last modified on

2023 Year 04 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057916